KINGSWAY MEDICAL CENTRE
KINGSWAY, BILLINGHAMHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 13 | 14 | 92.9% | |
HF 4 | 2011 | 9 | 11 | 81.8% | |
HF 4 | 2012 | 14 | 14 | 100.0% | |
HF 4 | 2013 | 23 | 23 | 100.0% | |
HF004 | 2014 | 25 | 26 | 96.2% | |
HF004 | 2015 | 24 | 25 | 96.0% | |
HF004 | 2016 | 25 | 27 | 92.6% | |
HF004 | 2017 | 35 | 37 | 94.6% | |
HF004 | 2018 | 49 | 50 | 98.0% | |
HF004 | 2019 | 73 | 74 | 98.6% | |
HF004 | 2020 | 72 | 75 | 96.0% | |
HF006 | 2021 | 69 | 73 | 94.5% | |
HF006 | 2022 | 68 | 70 | 97.1% | |
HF006 | 2023 | 75 | 76 | 98.7% |